4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000040
Chief Medical Officer sold 4,668 shares at $19.02 ($88,785)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ho Carole · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-10 | Sale : show line 1 in the form 10b5-1 | −4,668 | $19.02 | $88,785 | 147,794 | D |
| Open-market sales · 4,668 sh · avg $19.02 · $88,785 | ||||||
Loading xslF345X05/wk-form4_1705108724.xml…